Article

Plasmonic Photothermal Heating of Intraperitoneal Tumors through the Use of an Implanted Near-Infrared Source

Koch Institute for Integrative Cancer Research, ¶Health Sciences and Technology, and #Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology , Cambridge, Massachusetts, United States.
ACS Nano (Impact Factor: 12.03). 08/2013; 7(9). DOI: 10.1021/nn4033757
Source: PubMed

ABSTRACT Plasmonic nanomaterials including gold nanorods are effective agents for inducing heating in tumors. Because near-infrared (NIR) light has traditionally been delivered using extracorporeal sources, most applications of plasmonic photothermal therapy have focused on isolated subcutaneous tumors. For more complex models of disease such as advanced ovarian cancer, one of the primary barriers to gold nanorod-based strategies is the adequate delivery of NIR light to tumors located at varying depths within the body. To address this limitation, a series of implanted NIR illumination sources are described for the specific heating of gold nanorod-containing tissues. Through computational modeling and ex vivo studies, a candidate device is identified and validated in a model of orthotopic ovarian cancer. As the therapeutic, imaging, and diagnostic applications of plasmonic nanomaterials progress, effective methods for NIR light delivery to challenging anatomical regions will complement ongoing efforts to advance plasmonic photothermal therapy toward clinical use.

3 Followers
 · 
157 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background The interest for gold nanorods in biomedical optics is driven by their intense absorbance of near infrared light, their biocompatibility and their potential to reach tumors after systemic administration. Examples of applications include the photoacoustic imaging and the photothermal ablation of cancer. In spite of great current efforts, the selective delivery of gold nanorods to tumors through the bloodstream remains a formidable challenge. Their bio-conjugation with targeting units, and in particular with antibodies, is perceived as a hopeful solution, but the complexity of living organisms complicates the identification of possible obstacles along the way to tumors.ResultsHere, we present a new model of gold nanorods conjugated with anti-cancer antigen 125 (CA125) antibodies, which exhibit high specificity for ovarian cancer cells. We implement a battery of tests in vitro, in order to simulate major nuisances and predict the feasibility of these particles for intravenous injections. We show that parameters like the competition of free CA125 in the bloodstream, which could saturate the probe before arriving at the tumors, the matrix effect and the interference with erythrocytes and phagocytes are uncritical.Conclusions Although some deterioration is detectable, anti-CA125-conjugated gold nanorods retain their functional features after interaction with blood tissue and so represent a powerful candidate to hit ovarian cancer cells.
    Journal of Nanobiotechnology 12/2014; 12(1):55. DOI:10.1186/s12951-014-0055-3 · 4.08 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Conjugation of biomolecules on gold nanorod (GNR) surfaces is the basis for successful applications in biosensing, imaging, and drug delivery. Current functionalization methods are often problematic, involving multi-step nanoparticle modification to replace surfactant bilayer, delicate nanoparticle protection during surfactant exchange, and material loss due to inevitable aggregation. Instead of intensive surface modification of GNRs, we describe herein a facile method to functionalize gold nanorod surfaces via covalent Au-S bonds by thiolating receptors. The resulting GNR-bioconjugates showed superior dispersion and stability in buffer for months without morphology change and aggregation. ELISA tests confirmed the high biofunctionality of the thiolated anti-IgG moieties immobilized on the GNR surfaces. Furthermore, this simple method facilitated a straightforward functionalization of GNR assembly on glass substrate to construct a specific biochip, which can detect human IgG targets in a label-free fashion with high sensitivity and specificity. Compared to electropolymeric coating to functionalize the GNR, our method exhibited a five-fold enhancement in the spectral sensitivity to refractive index change caused by the target binding. This universal GNR bioconjugation method can be extended to bind different proteins and antibodies for development of biosensors or drug delivery. Copyright © 2015. Published by Elsevier B.V.
    Talanta 05/2015; 136. DOI:10.1016/j.talanta.2014.11.023 · 3.51 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nanotechnology plays an increasingly important role not only in our everyday life (with all its benefits and dangers) but also in medicine. Nanoparticles are to date the most intriguing option to deliver high concentrations of agents specifically and directly to cancer cells; therefore, a wide variety of these nanomaterials has been developed and explored. These span the range from simple nanoagents to sophisticated smart devices for drug delivery or imaging. Nanomaterials usually provide a large surface area, allowing for decoration with a large amount of moieties on the surface for either additional functionalities or targeting. Besides using particles solely for imaging purposes, they can also carry as a payload a therapeutic agent. If both are combined within the same particle, a theranostic agent is created. The sophistication of highly developed nanotechnology targeting approaches provides a promising means for many clinical implementations and can provide improved applications for otherwise suboptimal formulations. In this review we will explore nanotechnology both for imaging and therapy to provide a general overview of the field and its impact on cancer imaging and therapy.
    Critical reviews in oncogenesis 01/2014; 19(3-4):143-176. DOI:10.1615/CritRevOncog.2014011601

Preview (4 Sources)

Download
3 Downloads
Available from